MEGAKARYOCYTES IN CHRONIC MYELOPROLIFERATIVE DISORDERS - NUMERICAL DENSITY CORRELATED BETWEEN DIFFERENT ENTITIES

被引:22
作者
KALOUTSI, V [1 ]
FRITSCH, RS [1 ]
BUHR, T [1 ]
RESTREPOSPECHT, I [1 ]
WIDJAJA, W [1 ]
GEORGII, A [1 ]
机构
[1] MED HSCH HANNOVER,INST PATHOL,KONSTANTY GUTSCHOW STR 8,W-3000 HANNOVER 61,GERMANY
关键词
MEGAKARYOCYTES; CHRONIC MYELOPROLIFERATIVE DISORDERS; MORPHOMETRY; HISTOLOGY;
D O I
10.1007/BF01606498
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
A morphometric evaluation of number and grouping of megakaryocytes (MK) in five different groups of chronic myeloproliferative disorders (CMPD) was performed by counting 60 high power fields equaling approximately 14.28 mm2 of haematopoiesis in each case. Twenty-one up to 29 cases were evaluated for each of five categories of CMPD and one control group; a total of 132 cases of CMPD and 33 control cases were used. The mean number of MK per square millimetre was 15.54 +/- 1.53 in chronic myeloid leukaemia of common or granulocytic type (CML.CT), 69.91 +/- 5.85 in CML with megakaryocytic increase (CML.MI), 59.59 +/- 3.27 in polycythaemia vera (P. vera), 59.85 +/- 4.59 in primary thrombocythaemia (PTH), 67.58 +/- 4.11 in chronic megakaryocytic granulocytic myelosis (CMGM), and 19.7 +/- 3.07 in controls. The distinction between free or isolated MK, and between clustered or grouped MK corresponds to the total cell counts of MK in the various groups of CMPD. Clustering of MK was significantly higher in CMGM and PTH compared to other groups, but the difference between them was not statistically significant. Significant differences in the mean number of MK were obtained between controls and CML.CT on the one hand and all other groups of CMPD on the other. The results further support the histological sub-classification of CMPD according to the primary disorders of the Hannover classification (not advanced by sclerosis, fibrosis or excess of blasts, respectively).
引用
收藏
页码:493 / 497
页数:5
相关论文
共 26 条
[1]  
BARTL R, 1982, BONE MARROW BIOPSIES, P15
[2]  
BRANEHOG I, 1975, SCAND J HAEMATOL, V15, P321
[3]  
BRANEHOG I, 1982, SCAND J HAEMATOL, V29, P411
[4]   BONE-MARROW IN MEGAKARYOCYTIC DISORDERS [J].
BURKHARDT, R .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1988, 2 (04) :695-733
[6]  
Ellis J T, 1979, Pathol Annu, V14 Pt 1, P383
[7]  
ELLIS JT, 1975, SEMIN HEMATOL, V12, P433
[8]   MICROPLANIMETRIC STUDIES ON MEGAKARYOCYTES IN CHRONIC GRANULOCYTIC LEUKAEMIA AND POLYCYTHAEMIA VERA [J].
FRANZEN, S ;
STRENGER, G ;
ZAJICEK, J .
ACTA HAEMATOLOGICA, 1961, 26 (03) :182-+
[9]  
FRISCH B, 1984, BIBL HAEMATOL, V50, P57
[10]   CHRONIC MYELOPROLIFERATIVE DISORDERS IN BONE-MARROW BIOPSIES [J].
GEORGII, A ;
VYKOUPIL, KF ;
BUHR, T ;
CHORITZ, H ;
DOHLER, U ;
KALOUTSI, V ;
WERNER, M .
PATHOLOGY RESEARCH AND PRACTICE, 1990, 186 (01) :3-27